The ABSORB EXTEND study: preliminary report of the twelve-month clinical outcomes in the first 512 patients enrolled. - Wikidata - wikimedia - TriplyDB

The ABSORB EXTEND study: preliminary report of the twelve-month clinical outcomes in the first 512 patients enrolled.

The ABSORB EXTEND study: preliminary report of the twelve-month clinical outcomes in the first 512 patients enrolled.

http://www.wikidata.org/entity/Q38431418

about

Concise Review of Optical Coherence Tomography in Clinical Practice Bioresorbable vascular scaffolds technology: current use and future developments The Safety and Efficacy of Absorb Bioresorbable Vascular Scaffold: A Systematic Review Twelve months clinical outcome after bioresorbable vascular scaffold implantation in patients with stable angina and acute coronary syndrome. Data from the Polish National Registry Everolimus-Eluting Bioresorbable Vascular Scaffold in Real World Practice - A Single Center Experience.Angiographic and optical coherence tomography insights into bioresorbable scaffold thrombosis: single-center experience Clinical Outcomes of Bioresorbable Scaffold in Coronary Artery Disease: A Systematic Literature Review."Leaving nothing behind": is the bioresorbable vascular scaffold a new hope for patients with coronary artery disease?Bioresorbable Vascular Scaffolds in Interventional Neuroradiology.Bioresorbable polymeric scaffolds for coronary revascularization: Lessons learnt from ABSORB III, ABSORB China, and ABSORB Japan.Dual antiplatelet therapy, drug-eluting stents and bioresorbable vascular scaffolds: Evolutionary perspectives.Absorb bioresorbable stents for the treatment of coronary artery disease.The ABSORB bioresorbable vascular scaffold: A novel, fully resorbable drug-eluting stent: Current concepts and overview of clinical evidence.Differential aspects between cobalt-chromium everolimus drug-eluting stent and Absorb everolimus bioresorbable vascular scaffold: from bench to clinical use.Drug-eluting stents to prevent stent thrombosis and restenosis.From drug eluting stents to bioresorbable scaffolds; to new horizons in PCI.Bioresorbable vascular scaffold thrombosis in a consecutive cohort of 550 patients.Optimisation of percutaneous coronary intervention: indispensables for bioresorbable scaffolds.Bioresorbable Scaffolds for Coronary Stenosis: When and How Based Upon Current Studies.Bioresorbable vascular scaffolds - basic concepts and clinical outcome.Update on clinical evidence (Part II): A summary of the main post market studies.A review of bioresorbable scaffolds: hype or hope?Long-Term Follow-Up of Patients after Percutaneous Coronary Intervention with Everolimus-Eluting Bioresorbable Vascular Scaffold.IVUS-Guided Implantation of Bioresorbable Vascular Scaffolds for Very Late Paclitaxel Stent Thrombosis.Bioresorbable Vascular Scaffolds in a Real-World Patient Population-Results From a Mid-Term Angiographic Follow-Up.Angiographic and clinical outcomes of patients treated with everolimus-eluting bioresorbable stents in routine clinical practice: Results of the ISAR-ABSORB registry.Clinical outcomes following target lesion revascularization for bioresorbable scaffold failure.Clinical outcomes following bioresorbable scaffold implantation for bifurcation lesions: Overall outcomes and comparison between provisional and planned double stenting strategy.Current status of clinically available bioresorbable scaffolds in percutaneous coronary interventions.Two-year clinical outcomes of patients treated with overlapping absorb scaffolds: An analysis of the ABSORB EXTEND single-arm study.Assessment of bioresorbable scaffold with a novel high-definition 60 MHz IVUS imaging system: Comparison with 40-MHz IVUS referenced to optical coherence tomography.Bioresorbable Vascular Scaffold Korean Expert Panel Report.Current concepts on coronary revascularization using BRS in patients with diabetes and small vessels disease.Bioresorbable vascular scaffolds: From patient selection to optimal scaffold implantation; tips and tricks to minimize device failure.First reported use of drug-coated balloon for bioresorbable in-scaffold restenosis.Low major adverse cardiac event rates following bioresorbable vascular scaffold implantation: Impact of implantation technique on treatment outcomes.Bioresorbable Coronary Scaffolds: Deployment Tips and Tricks and the Future of the Technology.Cardiovascular stents: overview, evolution, and next generation

P2860

Q26741032-0788A075-40B1-4105-BCEC-5CFB2C80B95D Q26741147-686DA4B7-B870-43AB-9279-958046498A3D Q26782136-008621DF-32D9-46BD-A17B-D76E1FE86EA3 Q31106727-A1D6F803-4C8A-4918-B346-53BE7B3143EA Q33729836-2BF6214D-4216-4BE8-8D7F-3E33E60E9709 Q35787354-B8CE6374-567A-459F-8D76-8D307EB708D8 Q35884429-EA9EDC73-8746-48B8-AF30-A49983E580BA Q38285660-F3C6C429-5974-4DD8-B285-8EEDEEFCE5B0 Q38372817-1E0AD641-1C5C-4E9C-8205-AD6300489B14 Q38472279-DB643158-0DBC-43BC-B1DF-93EE64DFEF85 Q38563586-B8DE7F19-16BF-4D9B-9855-BB6B195FAA45 Q38573540-29F496EA-C19B-44D6-86DE-47E92756E38F Q38589504-19D10D53-B5DB-4F8C-8283-3793A9DA8BC3 Q38592121-A195D1E4-E431-4F03-852C-9314CA5926F0 Q38633332-C8CDFAF3-CFC5-43A6-9275-BBB767D7861D Q38702003-B92343E3-9D73-4306-881D-C461A46EF388 Q38824733-E13ED725-64DD-4C25-A3FF-3E78B13D2CF3 Q38885397-D3D04E32-34BA-4DBC-BD73-DC1F38C14C88 Q38904242-9CA4BB64-407B-4CD8-9DA5-3048586B521F Q38967027-F7F27134-79DB-461E-A2D2-272383624279 Q38994998-D2ADC252-0E89-44DE-8F3E-9DDAD9EBCC84 Q39014983-5426A257-CE4C-413F-B9D4-3AD1D0E4A8A6 Q39027044-87F79DC6-112E-4B26-9070-462077CBD595 Q39140488-8ACD4D7F-1CFF-4C42-9FB4-B7C52C58F9CF Q39665517-632082DC-2D17-4907-97B4-3A6DFEBABB92 Q40167885-10BA1331-2D1A-482D-8D33-626039C6CD3A Q40582846-E55BB498-6A52-4576-A230-3F5C9126C635 Q40899680-0FCC025B-58C5-4F6A-9426-ECB00DE84AEA Q41875719-9065657B-61A2-4DBB-B509-5E42DEC397D2 Q42696545-7C5A58C9-A0C8-4634-BAC4-4FAA0939FEF6 Q46228864-331F035E-E0E0-4E10-BBD5-6A0DD055AC82 Q47111093-AE5BD806-E768-419F-955C-6001FEFB313A Q47999843-8B18B08E-0E85-4AE3-ACC1-B449FE091EBB Q48949945-05E7D471-191D-4D34-9DFE-07D68AD9C4F3 Q49037026-DCC21F7B-F9F9-4662-838C-BCA7CF7D9026 Q49887665-45932230-EB72-4619-A3A7-AEF047297896 Q52603571-A3DA3E56-1C27-4F0C-83DC-0B63276D1FBD Q58752931-386D9B75-DBEE-477E-8BA1-E3AE116E3646

P2860

The ABSORB EXTEND study: preliminary report of the twelve-month clinical outcomes in the first 512 patients enrolled.

http://www.wikidata.org/entity/Q38431418

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

The ABSORB EXTEND study: preli ...... e first 512 patients enrolled.

@en

type

label

The ABSORB EXTEND study: preli ...... e first 512 patients enrolled.

@en

prefLabel

The ABSORB EXTEND study: preli ...... e first 512 patients enrolled.

@en

P1433

Q38431418-509B11B2-A555-401B-A342-AD560BA3DACF

P1476

Q38431418-EDE54567-8D9F-4904-9D8D-B40A3DE27CD0

P2093

Q38431418-1C199FD8-C580-45C4-A593-5D9D7AC82CE7

Q38431418-243827EF-37F7-4536-AEEC-BD00AF66EF00

Q38431418-4BDDE4A9-746B-45D8-971E-BC2B5D014D47

Q38431418-708E1384-A182-4B17-82DD-325FF6C630F3

Q38431418-7DD18B4C-C134-4E89-B858-858A6A446BB7

Q38431418-7F72BA16-7CA9-422D-BD30-BE8A5216E174

Q38431418-912D1276-08A9-4CC9-946A-22C095557669

Q38431418-9B312B0C-7D3D-446D-A7D3-096334326B52

Q38431418-A08DB976-EA24-423C-B263-B602791B51A0

Q38431418-D12C99EE-59DF-41F4-AB21-8D83E3ABBFAF

P304

Q38431418-03BC128D-2F0F-45D5-A886-098C885F16D9

P31

Q38431418-044352F4-2EBF-4726-90B7-8F571A7B0033

P356

Q38431418-26B85EA3-5FEC-42A3-9CF2-0C4E9D3CF7B0

P433

Q38431418-68CA2972-F51C-46F3-A296-1464651D3598

P478

Q38431418-6724E55F-9F15-4B05-BCAF-7D5429F6677F

P50

Q38431418-458E3E6C-0979-469A-9AC1-1A6213119664

P577

Q38431418-58BDE5F8-58FC-4E06-9276-5ADB3A94EA2F

P698

Q38431418-5804842F-43C5-4838-8350-4E4B0AC64821

P356

P1433

EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology

P1476

The ABSORB EXTEND study: preli ...... e first 512 patients enrolled.

@en

P2093

ABSORB EXTEND investigators

http://www.w3.org/2001/XMLSchema#string

Alexandre Abizaid

http://www.w3.org/2001/XMLSchema#string

Antonio L Bartorelli

http://www.w3.org/2001/XMLSchema#string

Ashok Seth

http://www.w3.org/2001/XMLSchema#string

Bernard Chevalier

http://www.w3.org/2001/XMLSchema#string

Cécile Dorange

http://www.w3.org/2001/XMLSchema#string

J Ribamar Costa

http://www.w3.org/2001/XMLSchema#string

Krishnankutty Sudhir

http://www.w3.org/2001/XMLSchema#string

Marrianne Stuteville

http://www.w3.org/2001/XMLSchema#string

Robert Jan van Geuns

http://www.w3.org/2001/XMLSchema#string

P304

1396-1401

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4244/EIJV10I12A243

http://www.w3.org/2001/XMLSchema#string

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P50

Patrick W Serruys

P577

2015-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24769555

http://www.w3.org/2001/XMLSchema#string